Giacomo Aimar

Cuneo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.

Journal: Tumori

Published: October 18, 2025

Patients with cancer and hospital admissions: disease trajectory and strategic choices.

Patients with cancer and hospital admissions: disease trajectory and strategic choices.

Journal: BMJ supportive & palliative care

Published: August 25, 2023

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2023

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study.

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study.

Journal: BMJ oncology

Published: December 05, 2022

Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).

Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).

Journal: Oncology reports

Published: July 21, 2022

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.

Journal: The oncologist

Published: January 28, 2022

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: August 03, 2021

Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.

Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.

Journal: Frontiers in oncology

Published: May 19, 2021

Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.

Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.

Journal: Clinical colorectal cancer

Published: March 02, 2021

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

Journal: Exploration of targeted anti-tumor therapy

Published: January 01, 2021

Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.

Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.

Journal: Oncology

Published: October 08, 2020

Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives.

Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives.

Journal: Expert opinion on pharmacotherapy

Published: September 25, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026